Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GUMDROPS telmisartan PET feasibility study
NL-OMON20821Unknown
- Sponsor
- University Medical Center Groningen
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of telmisartan in type 2 diabetes mellitus (T2DM) (3 cohorts), sponsored by University Medical Center Groningen. Primary endpoints: Dynamic PET data and images, Radiation count measurement and 1 more. Status: unknown.
02
Drugs
telmisartan
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON20821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20821.